Morgan Stanley initiated coverage on SeaWorld Entertainment with a new price target
$SEAS
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Morgan Stanley initiated coverage of SeaWorld Entertainment with a rating of Overweight and set a new price target of $70.00